Interestingly, the loss of dopaminergic neurons in the SN was significantly inhibited by the genetic ablation of caspase-1 or by treatment with a selective caspase-1 inhibitor in an animal PD model following the administration of MPTP or 6-hydroxydopamine administration [20, 45]. The gene discussed is CASP1; the disease is Parkinson disease.